A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human Volunteers
Open Access
- 15 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (10), 1491-1501
- https://doi.org/10.1086/592450
Abstract
Background. One strategy for improving anti-tuberculosis (TB) vaccination involves the use of recombinant bacille Calmette-Guérin (rBCG) overexpressing protective TB antigens. rBCG30, which overexpresses the Mycobacterium tuberculosis secreted antigen Ag85b, was the first rBCG shown to induce significantly greater protection against TB in animals than parental BCG. Methods. We report here the first double-blind phase 1 trial of rBCG30 in 35 adults randomized to receive either rBCG30 or parental Tice BCG intradermally. Clinical reactogenicity was assessed, and state-of-the-art immunological assays were used to study Ag85b-specific immune responses induced by both vaccines. Results. Similar clinical reactogenicity occurred with both vaccines. rBCG30 induced significantly increased Ag85b-specific T cell lymphoproliferation, interferon (IFN)-γ secretion, IFN-γ enzyme-linked immunospot responses, and direct ex vivo intracellular IFN-γ responses. Additional flow cytometry studies measuring carboxyfluorescein succinimidyl ester dilution and intracellular cytokine production demonstrated that rBCG30 significantly enhanced the population of Ag85b-specific CD4+ and CD8+ T cells capable of concurrent expansion and effector function. More importantly, rBCG30 significantly increased the number of Ag85b-specific T cells capable of inhibiting intracellular mycobacteria. Conclusions. These results provide proof of principal that rBCG can safely enhance human TB immunity and support further development of rBCG overexpressing Ag85b for TB vaccination.Keywords
This publication has 43 references indexed in Scilit:
- An Increase in Antimycobacterial Th1-Cell Responses by Prime-Boost Protocols of Immunization Does Not Enhance Protection against TuberculosisInfection and Immunity, 2006
- Mechanisms of MHC class I‐restricted antigen processing and cross‐presentationImmunological Reviews, 2005
- Enhancing the Protective Efficacy of Mycobacterium bovis BCG Vaccination against Tuberculosis by Boosting with the Mycobacterium tuberculosis Major Secretory ProteinInfection and Immunity, 2005
- Differential Effects of Control and Antigen-Specific T Cells on Intracellular Mycobacterial GrowthInfection and Immunity, 2003
- Investigation of the Relationships between Immune‐Mediated Inhibition of Mycobacterial Growth and Other Potential Surrogate Markers of ProtectiveMycobacterium tuberculosisImmunityThe Journal of Infectious Diseases, 2002
- CD4+and CD8+T Cells Mediate Adoptive Immunity to Aerosol Infection ofMycobacterium bovisBacillus Calmette‐GuérinThe Journal of Infectious Diseases, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- An Antimicrobial Activity of Cytolytic T Cells Mediated by GranulysinScience, 1998
- Functional diversity of helper T lymphocytesNature, 1996
- Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistanceEuropean Journal of Immunology, 1995